Company Overview Phadia develops, manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. Besides strategic management, administration and business development, the international centre in Uppsala incorporates extensive research and development facilities, a state-of-the-art production plant and distribution system operating cost-effectively around the clock. In Freiburg, Germany, a second centre develops and supports diagnostic tests for autoimmune diseases. Some 98% of production is exported to more than 3,000 laboratories in 60 countries. Supplying seven out of ten allergy laboratory tests worldwide, the company has remained the world leader in its field for more than 25 years. Key Facts - We are the world-leader in allergy IgE testing.
- We have 75% market share in in vitro allergy testing worldwide.
- We have 42% in autoimmune disease testing in Europe.
- We have 3,000 laboratories in 60 countries.
- In total, we employ 1,200 people worldwide.
- We have direct representation in 21 markets through wholly owned market companies and through distributors in many countries around the world.
- Our corporate headquarter is located in Uppsala, Sweden.
|
